Somani B K, Giusti G, Sun Y, Osther P J, Frank M, De Sio M, Turna B, de la Rosette J
Department of Urology, University Hospital Southampton, Southampton, UK.
Department of Urology, IRCCS San Raffaele Scientific Institute, Ville Turro Division, Milan, Italy.
World J Urol. 2017 Apr;35(4):675-681. doi: 10.1007/s00345-016-1909-0. Epub 2016 Aug 4.
Ureterorenoscopy (URS) is a popular and growing option for management of ureteric and renal stones. The CROES URS Global Study was set up to assess the outcomes of URS in a large worldwide cohort of patients involving multiple centres. In this paper, we analysed the database for intra-operative and post-operative complications associated with ureterorenoscopy.
The CROES database was established via collaboration between 114 centres in 32 countries worldwide, and information on both intra-operative and post-operative complications was collected electronically between January 2010 and October 2012.
On analysis of a total of 11,885 patients, the overall complication and stone-free rates were found to be 7.4 and 85.6 %, respectively. The intra-operative and post-operative complication rates were 4.2 and 2.6 %, respectively, and in total 5 deaths were reported in the study period. Taking into account different world economies, there were no differences in the complication rates between the developing and developed nations or between different centres from different continents.
Ureterorenoscopy is a safe and effective procedure for treatment of stones, the outcomes of which are broadly comparable in different parts of the world for similar patient and stone demographics.
输尿管肾镜检查（URS）是治疗输尿管结石和肾结石的一种常用且应用日益广泛的方法。CROES URS全球研究旨在评估在涉及多个中心的全球大量患者队列中输尿管肾镜检查的结果。在本文中，我们分析了与输尿管肾镜检查相关的术中及术后并发症数据库。
CROES数据库是通过全球32个国家的114个中心合作建立的，2010年1月至2012年10月期间以电子方式收集术中及术后并发症信息。
对总共11885例患者进行分析后发现，总体并发症发生率和结石清除率分别为7.4%和85.6%。术中及术后并发症发生率分别为4.2%和2.6%，研究期间共报告5例死亡。考虑到不同的世界经济体，发展中国家和发达国家之间或来自不同大陆的不同中心之间并发症发生率没有差异。
输尿管肾镜检查是治疗结石的一种安全有效的方法，在世界不同地区，对于类似患者和结石特征，其结果大致相当。
